PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

PET/CT with Fluorodeoxyglucose During Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Bibliographic Details
Main Authors:	Travaini, Laura L, Zampino, Maria G, Colandrea, Marzia, Ferrari, Mahila E, Gilardi, Laura, Leonardi, Maria C, Santoro, Luigi, Orecchia, Roberto, Grana, Chiara M
Format:	Online
Language:	English
Published:	Cancer Intelligence 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4817524/

Similar Items

Intramedullary spinal cord metastases from breast cancer: detection with 18F-FDG PET/CT
by: Gilardi, Laura, et al.
Published: (2013)

Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
by: Molinari, Chiara, et al.
Published: (2011)

Neoadjuvant chemoradiotherapy for rectal cancer: how important is tumour regression?
by: McCoy, M., et al.
Published: (2015)

Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer
by: Mihmanlı, Mehmet, et al.
Published: (2016)

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
by: Li, Yi, et al.
Published: (2016)

Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
by: Tokuhara, Katsuji, et al.
Published: (2016)

Correlation between tumor regression grade and rectal volume in neoadjuvant concurrent chemoradiotherapy for rectal cancer
by: Lee, Hong Seok, et al.
Published: (2016)

Prospective Analysis of 18F-FDG PET/CT Predictive Value in Patients with Low Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy and Conservative Surgery
by: Niccoli-Asabella, Artor, et al.
Published: (2014)

Chemoradiotherapy response in recurrent rectal cancer
by: Yu, Stanley K T, et al.
Published: (2014)

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
by: McCoy, M., et al.
Published: (2015)

Manometric evaluation of anorectal function in patients treated with neoadjuvant chemoradiotherapy and total mesorectal excision for rectal cancer
by: De Nardi, Paola, et al.
Published: (2017)

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
by: Svoboda, Marek, et al.
Published: (2012)

Negative impact of pretreatment anemia on local control after neoadjuvant chemoradiotherapy and surgery for rectal cancer
by: Lee, Hyebin, et al.
Published: (2012)

Value of transrectal ultrasonography for tumor node metastasis restaging in patients with locally advanced rectal cancer after neoadjuvant chemoradiotherapy
by: Peng, Hai-Hua, et al.
Published: (2013)

Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis
by: Francesca De Felice, et al.
Published: (2017-05-01)

Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy
by: Xin Wu, et al.
Published: (2018-05-01)

The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
by: Anaïs Chauvin, et al.
Published: (2018-04-01)

Factors associated with rectal tumor and their influence on tumor regression grade after neoadjuvant chemoradiotherapy
by: Yu R Aliyarov
Published: (2018-08-01)

The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer
by: Liu, Guo-Chen, et al.
Published: (2015)

Pharmacogenetics Biomarkers and Their Specific Role in Neoadjuvant Chemoradiotherapy Treatments: An Exploratory Study on Rectal Cancer Patients
by: Dreussi, Eva, et al.
Published: (2016)

Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy
by: Huang, Xuan-zhang, et al.
Published: (2016)

Treatment Interval between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer Patients: A Population-Based Study
by: Rombouts, A. J. M., et al.
Published: (2016)

Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy
by: Chen, Yuan-Gui, et al.
Published: (2016)

Elevated CA19-9 as the Most Significant Prognostic Factor in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy
by: Zhang, Lu-Ning, et al.
Published: (2015)

Effect of Neoadjuvant Chemoradiotherapy with Capecitabine versus Fluorouracil for Locally Advanced Rectal Cancer: A Meta-Analysis
by: Liu, Guo-Chen, et al.
Published: (2016)

Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy
by: Zhang, Lu-Ning, et al.
Published: (2015)

Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy
by: Xiao, Lin, et al.
Published: (2016)

GRP78 Protein Expression as Prognostic Values in Neoadjuvant Chemoradiotherapy and Laparoscopic Surgery for Locally Advanced Rectal Cancer
by: Lee, Hee Yeon, et al.
Published: (2015)

Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
by: McCoy, M J, et al.
Published: (2015)

Clinical parameters predicting pathologic complete response following neoadjuvant chemoradiotherapy for rectal cancer
by: Zeng, Wei-Gen, et al.
Published: (2015)

Evaluation of treatment response and tissue necrosis as prognostic indicators following neoadjuvant chemoradiotherapy in rectal cancer patients
by: Jung, Ji-Han, et al.
Published: (2016)

Prognostic significance of clinical and pathological stages on locally advanced rectal carcinoma after neoadjuvant chemoradiotherapy
by: Wen, Bixiu, et al.
Published: (2015)

Apparent diffusion coefficient measurement covering complete tumor area better predicts rectal cancer response to neoadjuvant chemoradiotherapy
by: Blažić, Ivana, et al.
Published: (2015)

Role of autophagy-related protein expression in patients with rectal cancer treated with neoadjuvant chemoradiotherapy
by: Shim, Byoung Yong, et al.
Published: (2016)

The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
by: Meng, Xiangjiao, et al.
Published: (2014)

Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity
by: Wang, Chia-Chun, et al.
Published: (2014)

Clinical Outcome of Patients with Complete Pathological Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancers: The Indian Scenario
by: Sinukumar, Snita, et al.
Published: (2014)

Locally Advanced Rectal Cancer: Does Assessment of Response After Neoadjuvant Chemoradiotherapy Impact Management?
by: Wolf, Elizabeth A., et al.
Published: (2013)

Effect of Interval between Neoadjuvant Chemoradiotherapy and Surgery on Oncological Outcome for Rectal Cancer: A Systematic Review and Meta-Analysis
by: Wang, Xiao-Jie, et al.
Published: (2016)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
by: Ferrari, Linda, et al.
Published: (2015)